Pyrrolidine-3-carboxylic acids as endothelin antagonists.: 5.: Highly selective, potent, and orally active ETA antagonists

被引:34
作者
Jae, HS [1 ]
Winn, M [1 ]
von Geldern, TW [1 ]
Sorensen, BK [1 ]
Chiou, WJ [1 ]
Nguyen, B [1 ]
Marsh, KC [1 ]
Opgenorth, TJ [1 ]
机构
[1] Abbott Labs, Metab Dis Res & Drug Anal Dept, Pharmaceut Prod Res Div, Abbott Pk, IL 60064 USA
关键词
D O I
10.1021/jm010237l
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and structure-activity relationships (SAR) of a series of pyrrolidine-3-carboxylic acids as endothelin antagonists are described. The data shows an increase in selectivity when the methoxy of Atrasentan (ABT-627) is replaced with methyl, and the benzodioxole is replaced with dihydrobenzofuran. Adding a fluorine further increases the binding activity and provides a metabolically stable and orally bioavailable ETA-selective antagonist.
引用
收藏
页码:3978 / 3984
页数:7
相关论文
共 28 条
[1]  
Ali H, 2000, J CARDIOVASC PHARM, V36, pS69
[2]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[3]  
[Anonymous], 1994, CURR MED CHEM
[4]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[5]   Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity [J].
Boyd, SA ;
Mantei, RA ;
Tasker, AS ;
Liu, G ;
Sorensen, BK ;
Henry, KJ ;
von Geldern, TW ;
Winn, M ;
Wu-Wong, JSR ;
Chiou, WJ ;
Dixon, DB ;
Hutchins, CW ;
Marsh, KC ;
Nguyen, E ;
Opgenorth, TJ .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) :991-1002
[6]   Selective antagonism of the ETA receptor reduces neointimal hyperplasia after balloon-induced vascular injury in pigs [J].
Burke, SE ;
Lubbers, NL ;
Gagne, GD ;
Wessale, JL ;
Dayton, BD ;
Wegner, CD ;
Opgenorth, TJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 30 (01) :33-41
[7]   The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats [J].
Chen, SJ ;
Chen, YF ;
Opgenorth, TJ ;
Wessale, JL ;
Meng, QC ;
Durand, J ;
DiCarlo, VS ;
Oparil, S .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1997, 29 (06) :713-725
[8]  
Dawas K, 1999, ANN ROY COLL SURG, V81, P306
[9]   PALLADIUM-CATALYZED COUPLING OF ARYL TRIFLATES WITH ORGANOSTANNANES [J].
ECHAVARREN, AM ;
STILLE, JK .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (18) :5478-5486
[10]  
GOLFMAN LS, 1993, CAN J CARDIOL, V9, P635